
Sign up to save your podcasts
Or


We love to hear from our listeners. Send us a message.
Ray Therapeutics' Co-Founder and CEO, Paul Bresge, joins Host Erin Harris to talk about optogenetics and how the company’s optogenetics approach differs from other gene therapies on the market developed to restore vision in retinal diseases like retinitis pigmentosa.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
By Erin Harris4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Ray Therapeutics' Co-Founder and CEO, Paul Bresge, joins Host Erin Harris to talk about optogenetics and how the company’s optogenetics approach differs from other gene therapies on the market developed to restore vision in retinal diseases like retinitis pigmentosa.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn

3,447 Listeners

756 Listeners

154 Listeners

818 Listeners

113,121 Listeners

10,331 Listeners

337 Listeners

6,592 Listeners

5,610 Listeners

6,462 Listeners

85 Listeners

5,576 Listeners

11,013 Listeners

16 Listeners

1,480 Listeners